Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Inflamm Bowel Dis ; 26(5): 678-686, 2020 04 11.
Artigo em Inglês | MEDLINE | ID: mdl-31943022

RESUMO

BACKGROUND: Intestinal fibrosis is a hallmark of Crohn's disease. Here, we investigated the impact of several putative antifibrotic compounds on the expression of fibrosis markers using murine precision-cut intestinal slices. METHODS: Murine precision-cut intestinal slices were cultured for 48 hours in the presence of profibrotic and/or antifibrotic compounds. The fibrotic process was studied on gene and protein level using procollagen 1a1 (Col1α1), heat shock protein 47 (Hsp47), fibronectin (Fn2), and plasminogen activator inhibitor-1 (Pai-1). The effects of potential antifibrotic drugs mainly inhibiting the transforming growth factor ß (TGF-ß) pathway (eg, valproic acid, tetrandrine, pirfenidone, SB203580, and LY2109761) and compounds mainly acting on the platelet-derived growth factor (PDGF) pathway (eg, imatinib, sorafenib, and sunitinib) were assessed in the model at nontoxic concentrations. RESULTS: Murine precision-cut intestinal slices remained viable for 48 hours, and an increased expression of fibrosis markers was observed during culture, including Hsp47, Fn2, and Pai-1. Furthermore, TGF-ß1 stimulated fibrogenesis, whereas PDGF did not have an effect. Regarding the tested antifibrotics, pirfenidone, LY2109761, and sunitinib had the most pronounced impact on the expression of fibrosis markers, both in the absence and presence of profibrotic factors, as illustrated by reduced levels of Col1α1, Hsp47, Fn2, and Pai-1 after treatment. Moreover, sunitinib significantly reduced Hsp47 and Fn2 protein expression and the excretion of procollagen 1. CONCLUSIONS: Precision-cut intestinal slices can successfully be used as a potential preclinical screening tool for antifibrotic drugs. We demonstrated that sunitinib reduced the expression of several fibrosis markers, warranting further evaluation of this compound for the treatment of intestinal fibrosis.


Assuntos
Avaliação Pré-Clínica de Medicamentos/métodos , Inibidores Enzimáticos/farmacologia , Fármacos Gastrointestinais/farmacologia , Intestinos/efeitos dos fármacos , Transdução de Sinais/efeitos dos fármacos , Animais , Colágeno Tipo I/efeitos dos fármacos , Cadeia alfa 1 do Colágeno Tipo I , Doença de Crohn/tratamento farmacológico , Doença de Crohn/patologia , Fibronectinas/efeitos dos fármacos , Fibrose/tratamento farmacológico , Fibrose/patologia , Proteínas de Choque Térmico HSP47/efeitos dos fármacos , Intestinos/patologia , Camundongos , Fator de Crescimento Derivado de Plaquetas/efeitos dos fármacos , Serpina E2/efeitos dos fármacos , Sunitinibe/farmacologia , Fator de Crescimento Transformador beta/antagonistas & inibidores
2.
Food Chem ; 196: 1137-43, 2016 Apr 01.
Artigo em Inglês | MEDLINE | ID: mdl-26593599

RESUMO

Oxidative stress and inflammation are involved in the development of obesity, type 2 diabetes and vascular complications. Systemic inflammation, as seen in obesity, is associated with high plasmatic levels of pro-inflammatory, pro-atherogenic and pro-thrombotic adipokines. Here we studied the effects of lyophilized cranberries (LCB) on the secretion and expression of PAI-1, IL-6, MCP-1 and leptin in mature 3T3-L1 adipocytes under baseline conditions and excessive inflammatory response elicitation by stimulation with H2O2. Our data demonstrated that LCB significantly reduced the expression and secretion of IL-6, MCP-1 and leptin, as well as suppressed the overexpression of PAI-1 induced by H2O2. Our findings suggested that LCB counteracted the stimulatory effect of H2O2 on secretion and expression of pro-inflammatory adipokines, implying a potential anti-inflammatory effect during the inflammatory process induced via oxidative stress in adipose tissue.


Assuntos
Adipócitos/metabolismo , Citocinas/metabolismo , Frutas , Inflamação/induzido quimicamente , Preparações de Plantas/farmacologia , Vaccinium , Células 3T3-L1 , Adipócitos/efeitos dos fármacos , Animais , Anti-Inflamatórios/farmacologia , Citocinas/efeitos dos fármacos , Peróxido de Hidrogênio/farmacologia , Inflamação/tratamento farmacológico , Leptina/metabolismo , Camundongos , Serpina E2/efeitos dos fármacos , Serpina E2/metabolismo
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA